Volume 3 Supplement 1

Proceedings of the 2015 Australia and New Zealand Academy for Eating Disorders (ANZAED) Conference: Riding the Waves to Recovery

Open Access

Exploring the effects of a family admissions program for adolescents with Anorexia Nervosa

  • Keren Fink1Email author,
  • Paul Rhodes1,
  • Stephen Touyz1,
  • Andrew Wallis2,
  • Jane Miskovic2,
  • Sloane Madden2 and
  • Michael Kohn2
Journal of Eating Disorders20153(Suppl 1):O48

DOI: 10.1186/2050-2974-3-S1-O48

Published: 23 November 2015

The present study aimed to qualitatively investigate patient experience and treatment efficacy of the Family Admissions Program (FAP) – a pilot treatment program being run at the Children's Hospital at Westmead for adolescents with Anorexia Nervosa (AN). Based on Maudsley Family Based Treatment (MFBT), the FAP involves an adolescent and his/her family undergoing a two-week family-based hospital admission at the outset of treatment. The program aims to increase intensity and support to a level needed by families at risk of responding negatively to traditional MFBT.

Narrative Inquiry and Interpretative Phenomenological Analysis (IPA) were used to analyse data obtained from participant interviews, exploring both the prospective expectations and retrospective experiences of families and clinicians participating in the program. Results from both of the qualitative analyses indicate that in cases where the family unit has been particularly fractured as a result of AN, the FAP offers an opportunity for relational strengthening and reunification, particularly within the parental subsystem. Combined with the program's intensive support, contained transition from hospital to home, and proximity to necessary hospital services, this serves to provide struggling families and parents with a more skilled and consolidated foundation for traditional outpatient MFBT.

Authors’ Affiliations

(1)
University of Sydney
(2)
Children's Hospital at Westmead

Copyright

© Fink et al. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement